@article{b2cc6dcb05a1495198e35fef0ad720dc,
title = "Biomarkers and new-onset atrial fibrillation to assess atrial cardiomyopathy",
author = "Dominik Linz and Elliott, {Adrian D.} and Marwick, {Thomas H.} and Prashanthan Sanders",
note = "Funding Information: Dr Linz reports having served on the advisory board of LivaNova and Medtronic. Dr Linz reports having received lecture and/or consulting fees from LivaNova, Medtronic, Pfizer and ResMed. Dr Linz reports having received research funding from Sanofi , ResMed and Medtronic . Dr Sanders reports having served on the advisory board of Biosense-Webster, Medtronic, St Jude Medical, Boston Scientific and CathRx. Dr Sanders reports having received lecture and/or consulting fees from Biosense-Webster, Medtronic, St Jude Medical, and Boston Scientific. Dr Sanders reports having received research funding from Medtronic , St Jude Medical , Boston Scientific , Biotronik and Sorin . Funding Information: Dr Linz is supported by a Beacon Research Fellowship by the University of Adelaide. Dr Elliott is supported by a postdoctoral fellowship from the National Heart Foundation of Australia. Dr Sanders is supported by Practitioner Fellowships from the National Health and Medical Research Council of Australia and by the National Heart Foundation of Australia. ",
year = "2017",
month = dec,
day = "1",
doi = "10.1016/j.ijcard.2017.08.031",
language = "English",
volume = "248",
pages = "208--210",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
}